Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen Abnormalities”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01184651
What this trial is testing

Tweens to Teens Project at Penn State

Who this might be right for
Congenital Adrenal Hyperplasia
Penn State University 188
Not applicableStudy completedNCT04807231
What this trial is testing

Comparison Between Calculated Bioavailable Testosterone Level With Radio-immunoassay Result.

Who this might be right for
TestosteroneAndrogens
Centre Hospitalier Universitaire, Amiens 270
Not applicableUnknownNCT01852786
What this trial is testing

The Effect of Hormonal Contraception on Female

Who this might be right for
Adverse Effect of Oral Contraceptives, Initial Encounter
Lithuanian University of Health Sciences 340
Early research (Phase 1)Ended earlyNCT05241613
What this trial is testing

AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc 28
Not applicableEnded earlyNCT02139774
What this trial is testing

Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 15
Not applicableWithdrawnNCT05062174
What this trial is testing

Breast Cancer BRCA1 Carriers: a Pilot Study

Who this might be right for
BRCA1 MutationHigh-grade Serous Ovarian CancerTNBC - Triple-Negative Breast Cancer
Indiana University
Post-approval studies (Phase 4)Study completedNCT00493987
What this trial is testing

The Role of 5-alpha Reductase in Mediating Testosterone Actions

Who this might be right for
Healthy
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 184
Not applicableUnknownNCT05647356
What this trial is testing

The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2

Who this might be right for
Polycystic Ovary SyndromeAndrogen ExcessMetabolic Disease
Royal College of Surgeons, Ireland 16
Not applicableStudy completedNCT03088046
What this trial is testing

Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome

Who this might be right for
AnovulationPolycystic Ovary SyndromeHyperandrogenism
Fundacion Dexeus 15
Testing effectiveness (Phase 2)UnknownNCT03050866
What this trial is testing

Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)

Who this might be right for
Circulating Tumor CellMetastatic Prostate Cancer
Erasmus Medical Center 140
Not applicableStudy completedNCT03898440
What this trial is testing

Fetal Ano-genital Distance in 2D Ultrasound.

Who this might be right for
Urogenital AbnormalitiesPrenatal DisorderSex Development Disorder
University Hospital, Brest 318
Testing effectiveness (Phase 2)Study completedNCT00878436
What this trial is testing

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

Who this might be right for
Prostate CancerProstatic Neoplasms
NYU Langone Health 52
Testing effectiveness (Phase 2)Study completedNCT01889199
What this trial is testing

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women

Who this might be right for
Polycystic Ovary Syndrome (PCOS)
University of California, Los Angeles 23
Testing effectiveness (Phase 2)Looking for participantsNCT07190300
What this trial is testing

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Novartis Pharmaceuticals 181
Testing effectiveness (Phase 2)Ended earlyNCT02348281
What this trial is testing

Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients

Who this might be right for
Breast Cancer
Fudan University 1
Not applicableUnknownNCT05157373
What this trial is testing

The Effect of Androgen Receptor Polymorphism on Endometrial Cancer

Who this might be right for
Androgen Receptor AbnormalEndometrial Disorder
University of Nicosia 150
Early research (Phase 1)Ended earlyNCT02574910
What this trial is testing

Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1

Who this might be right for
Congenital Adrenal Hyperplasia
University of Texas Southwestern Medical Center 4
Large-scale testing (Phase 3)Ended earlyNCT04869943
What this trial is testing

Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Veru Inc. 52
Testing effectiveness (Phase 2)Looking for participantsNCT06365788
What this trial is testing

Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
Universitaire Ziekenhuizen KU Leuven 53
Not applicableUnknownNCT04710186
What this trial is testing

AR, IGF-IR, IR and Peripheral Artery Disease

Who this might be right for
Androgen Receptor AbnormalInsulin-Like Growth Factor I DeficiencyInsulin Receptor, Defect in
University of Catanzaro 30
Next Page